A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Lead Manufacturing Technician

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeNorton, MA, USA$82.8k - $112k

About the Job

Requirements

  • A Bachelor of Science degree is preferred, with a minimum of 5–7 years of experience in a regulated GMP facility; equivalent combinations of education and industry experience may substitute for the minimum requirements.
  • Possess mechanical and scientific aptitude and document work clearly and thoroughly on existing forms and records.
  • Demonstrate commitment to maintaining a safe, compliant work environment.
  • Support effective and efficient production operations with strong attention to detail in execution and documentation.
  • Execute strenuous, sometimes repetitive physical work on a manufacturing shift schedule in classified cleanroom environments.
  • Lift objects up to 50 pounds and push or pull objects, including bulk materials up to 250 pounds, with assistance.
  • Wear half-face and full-face respirators or powered air-purifying respirators as required for chemical processing.
  • Work independently and in a team setting, with strong organizational skills.
  • Lead and mentor peers and interact with department management.
  • Communicate effectively in written and spoken English.
  • Support shift hours including days, nights, weekends, rotating shifts, on-call coverage, or extended hours.

Responsibilities

  • Execute cGMP manufacturing operations using approved standard operating procedures and batch records, with timely, accurate documentation.
  • Troubleshoot equipment and process issues, coordinate with support groups, and create work requests to minimize production impact.
  • Maintain a safe, compliant work environment by promptly reporting incidents, identifying risks, and supporting safety investigations and corrective and preventive actions.
  • Initiate and own deviations, corrective and preventive actions, and other electronic quality management system records; complete investigations and required documentation revisions in partnership with Quality Assurance and leadership.
  • Maintain equipment and room logbooks, review executed batch records, and support right-first-time and cycle-time objectives.
  • Serve as a qualified trainer and unit operation owner across multiple manufacturing areas, including complex operations such as chemical synthesis and high-performance liquid chromatography; create or revise applicable Unicorn methods.
  • Support continuous improvement, new product introduction and technology transfer activities, engineering test plans, validation protocols, and off-hours on-call needs as required.
  • Manufacture good manufacturing practice products in Train 1 at the Norton Manufacturing Facility, ensuring safe, efficient, and cGMP-compliant operations.
  • Operate production equipment in weigh/dispense, solution preparation, chemical synthesis, cleavage and deprotection, ultrafiltration/diafiltration, high-performance liquid chromatography, annealing, concentration, and lyophilization.
  • Interact with support groups, including Facilities, Process Development, Quality Control, Quality Assurance, and Validation, to support accurate and well-managed daily plant activities.
  • Provide backup coverage to the shift supervisor.

Desired Qualifications

  • Familiarity with Unicorn, Microsoft Word, and Microsoft Excel.
  • Prior experience training peers.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs